In a recent study, p53M237I, which accumulates within amyloid-like p53 oligomers in glioblastoma-derived cells, was indicated to exhibit GOF as cells expressing the M237I-p53 mutant were more resistant to temozolomide (TMZ) treatment than cells expressing WT p53 [83]. This evidence concerns the gene TP53 and glioblastoma.